This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

---

---

Omeprazole

GASTROGARD, LOSEC – Merial Canada Inc. (NOC Search)

Patents:

• 1127158: APOTEX
• 1129417: APOTEX
• 1234118: APOTEX, RHOXALPHARMA, REDDY
• 1264751: GENPHARM, PHARMASCIENCE, NOVOPHARM, REDDY, APOTEX, RHOXALPHARMA
• 1292693: APOTEX, REDDY, RHOXALPHARMA, NOVOPHARM, PHARMASCIENCE, GENPHARM
• 1302891: RHOXALPHARMA, SANDOZ, NOVOPHARM, APOTEX, REDDY, GENPHARM, PHARMASCIENCE
• 1302897: APOTEX
• 1327010: NOVOPHARM
• 1330759: NOVOPHARM
• 1338377: REDDY, RHOXALPHARMA, APOTEX, GENPHARM, NU-PHARM
• 2025668: APOTEX, NOVOPHARM, GENPHARM
• 2133762: APOTEX, NOVOPHARM, GENPHARM, NU-PHARM
• 2166482: PHARMASCIENCE
• 2166483: NOVOPHARM, RHOXALPHARMA, APOTEX, GENPHARM
• 2166794: GENPHARM, APOTEX, NU-PHARM, PHARMASCIENCE, NOVOPHARM, APOTEX, RHOXALPHARMA
• 2170647: GENPHARM
• 2179535: APOTEX
• 2180535: APOTEX
• 2186037: SANDOZ, GENPHARM, NOVOPHARM, APOTEX,
• 2284470: APOTEX,
• 4786505: APOTEX

Unknown/Other

• PM(NOC) – T-1954-02 – T-262-04
• Appeal – A-334-04

APOTEX

• Section 8 – T-2300-05 (2007 FC 696, 2009 FC 120, 2012 FC 559)
• Appeal – A-153-04 – A-154-04 – A-177-04 – A-187-12 (2013 FCA 77, 2016 FCA 194) – A-201-15 (2017 FCA 9) – A-211-11 (2012 FCA 68) – A-253-17 – A-254-17 – A-29-04 – A-291-04 – A-293-04 – A-298-13 (2014 FCA 142) – A-311-12 – A-311-15 – A-314-11 – A-397-09 – A-40-17 – A-41-17 – A-412-09 – A-452-11 (2012 FCA 322) – A-458-04 – A-459-04 – A-535-04 – A-536-04 – A-563-02 – A-587-05 – A-636-02 – A-71-09 – A-77-08 (2008 FCA 416) – A-90-03
• PM(NOC) – A-319-17 (2019 FCA 97) – A-634-00 – A-684-00 – T-1281-05 – T-1287-05 – T-1372-10 (2010 FC 1310, 2011 FC 1308) – T-1438-05 – T-148-02 – T-1575-09 – T-1747-00 – T-178-98 – T-179-98 – T-180-98 – T-1878-02 (2008 FC 184) – T-2011-15 (2017 FC 857) – T-2016-99 – T-2026-99 – T-2100-07 (2009 FC 721) – T-22-08 – T-2311-01 – T-260-04 – T-261-04 – T-373-08 – T-374-08 – T-377-08 (2008 FC 537) – T-47-08 – T-470-02 – T-812-02 – T-9-08 – T-951-08 – T-985-05 (2007 FC 688, 2007 FC 871, 2009 FC 822)
• Infringement – T-1409-04 (2008 FC 1301, 2011 FC 862, 2015 FC 671, 2016 FC 865, 2017 FC 378, 2017 FC 726, 2011 FC 598, 2015 FC 322) – T-1890-11 – T-2146-03 (2007 FC 683)

APOTEX, NU-PHARM

• Appeal – A-80-04

GENPHARM

• Appeal – A-607-03
• PM(NOC) – A-660-00 – T-155-04 – T-2005-01 – T-809-99

NOVOPHARM

• PM(NOC) – T-1186-06 – T-1590-06 – T-1778-06

NU-PHARM

• PM(NOC) – T-748-04 – T-764-04

PHARMASCIENCE

• PM(NOC) – T-1712-10

REDDY

• PM(NOC) – A-602-01
• Correction of Patent Office Records – T-1443-99 – T-1444-99

RHOXALPHARMA

• PM(NOC) – A-297-99 – T-366-98

SANDOZ

• PM(NOC) – T-705-07

---

Return to the Patented Medicine Litigation page.